<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04704869</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-19-0272</org_study_id>
    <nct_id>NCT04704869</nct_id>
  </id_info>
  <brief_title>Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation</brief_title>
  <official_title>A Multi-center, Randomized, Controlled Trial Evaluating the Effects of Early High-Dose Cryoprecipitate in Adult Patients With Major Trauma Hemorrhage Requiring Major Hemorrhage Protocol (MHP) Activation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queen Mary University of London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NHS Blood and Transplant</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to compare standard of care (SOC) massive transfusion protocol&#xD;
      to SOC massive transfusion protocol plus early use of cryoprecipitate (within 90 minutes of&#xD;
      emergency department arrival).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality at 28 days</measure>
    <time_frame>28 days after emergency department (ED) admission</time_frame>
    <description>Mortality from any cause</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality at 6 hours</measure>
    <time_frame>6 hours after ED admission</time_frame>
    <description>Mortality from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality at 24 hours</measure>
    <time_frame>24 hours after ED admission</time_frame>
    <description>Mortality from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality at 6 months</measure>
    <time_frame>6 months after ED admission</time_frame>
    <description>Mortality from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality at 12 months</measure>
    <time_frame>12 months after ED admission</time_frame>
    <description>Mortality from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death from bleeding at 6 hours</measure>
    <time_frame>6 hours after ED admission</time_frame>
    <description>Death related to exsanguination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death from bleeding at 24 hours</measure>
    <time_frame>24 hours after ED admission</time_frame>
    <description>Death related to exsanguination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirements (Number of units of red blood cells (RBCs))</measure>
    <time_frame>from time of pre-hospital care to 24 hours after ED admission</time_frame>
    <description>Number of units of RBCs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirements (Number of units of plasma)</measure>
    <time_frame>from time of pre-hospital care to 24 hours after ED admission</time_frame>
    <description>Number of units of plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirements (Number of units of platelets)</measure>
    <time_frame>from time of pre-hospital care to 24 hours after ED admission</time_frame>
    <description>Number of units of platelets</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfusion requirements (Number of units of cryoprecipitate)</measure>
    <time_frame>from time of pre-hospital care to 24 hours after ED admission</time_frame>
    <description>Number of units of cryoprecipitate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Destination of participant at time of discharge from hospital</measure>
    <time_frame>at the time of discharge from hospital, about 1-8 days after admission</time_frame>
    <description>Disposition of subject at time of discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life as assessed by EuroQol-5 dimension-5 level (EQ5D-5L)</measure>
    <time_frame>Day of hospital discharge or 28 days after ED admission (whichever comes first)</time_frame>
    <description>EQ5D-5L is reported as an index score ranging from 0 to 1, where 0 is the health state equivalent to dead and 1 is the health state equivalent to full health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life as assessed by the Glasgow Outcome Score</measure>
    <time_frame>Day of hospital discharge or 28 days after ED admission (whichever comes first)</time_frame>
    <description>The Glasgow Outcome Score ranges from 1 to 5, with a higher score indicating a better outcome:&#xD;
Death - Severe injury or death without recovery of consciousness&#xD;
Persistent vegetative state - Severe damage with prolonged state of unresponsiveness and a lack of higher mental functions&#xD;
Severe disability - Severe injury with permanent need for help with daily living&#xD;
Moderate disability - No need for assistance in everyday life, employment is possible but may require special equipment&#xD;
Low disability - Light damage with minor neurological and psychological deficits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life as assessed by EuroQol-5 dimension-5 level (EQ5D-5L)</measure>
    <time_frame>6 months after ED admission</time_frame>
    <description>EQ5D-5L is reported as an index score ranging from 0 to 1, where 0 is the health state equivalent to dead and 1 is the health state equivalent to full health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life as assessed by the Glasgow Outcome Score</measure>
    <time_frame>6 months after ED admission</time_frame>
    <description>The Glasgow Outcome Score ranges from 1 to 5, with a higher score indicating a better outcome:&#xD;
Death - Severe injury or death without recovery of consciousness&#xD;
Persistent vegetative state - Severe damage with prolonged state of unresponsiveness and a lack of higher mental functions&#xD;
Severe disability - Severe injury with permanent need for help with daily living&#xD;
Moderate disability - No need for assistance in everyday life, employment is possible but may require special equipment&#xD;
Low disability - Light damage with minor neurological and psychological deficits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital resource use as assessed by number of ventilator days</measure>
    <time_frame>Day of hospital discharge or 28 days after ED admission (whichever comes first)</time_frame>
    <description>Number of ventilator days during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital resource use as assessed by number of intensive care unit (ICU) days</measure>
    <time_frame>Day of hospital discharge or 28 days after ED admission (whichever comes first)</time_frame>
    <description>Number of ICU days during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital resource use as assessed by number of hospital days</measure>
    <time_frame>Day of hospital discharge or 28 days after ED admission (whichever comes first)</time_frame>
    <description>Total number of hospital days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Trauma Injury</condition>
  <arm_group>
    <arm_group_label>Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cryoprecipitate will be given in addition to the standard of care massive transfusion protocol products, which include red blood cells, plasma, platelets and whole blood. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only standard of care massive transfusion protocol products will be given, including red blood cells, plasma, platelets, and whole blood.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cryoprecipitate</intervention_name>
    <description>Cryoprecipitate is a blood product high in fibrinogen. The Cryoprecipitate will be given with 90 minutes of emergency department arrival. Cryoprecipitate dose will be 3 pools (equivalent to 15 single units).</description>
    <arm_group_label>Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Red Blood Cells</intervention_name>
    <description>RBCs are utilized as part of the Massive Transfusion protocol for hemorrhage control.</description>
    <arm_group_label>Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <arm_group_label>Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <other_name>RBCs</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Plasma</intervention_name>
    <description>Plasma is utilized as part of the Massive Transfusion protocol for hemorrhage control.</description>
    <arm_group_label>Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <arm_group_label>Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Platelets</intervention_name>
    <description>Platelets are utilized as part of the Massive Transfusion protocol for hemorrhage control.</description>
    <arm_group_label>Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <arm_group_label>Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Whole Blood</intervention_name>
    <description>Whole Blood is utilized as part of the Massive Transfusion protocol for hemorrhage control.</description>
    <arm_group_label>Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
    <arm_group_label>Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is judged to be an adult (according to local practice, e.g. 16 years or&#xD;
             older in UK) and has sustained severe traumatic injury. In the event the age is&#xD;
             unknown, estimated body weight â‰¥50 kg.&#xD;
&#xD;
          -  The patient is deemed by the attending clinician to have on-going active hemorrhage&#xD;
             AND REQUIRES Activation of the local major hemorrhage protocol for management of&#xD;
             severe blood loss AND HAS STARTED or HAS RECEIVED at least one unit of any blood&#xD;
             component&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient has been transferred from another hospital&#xD;
&#xD;
          -  The trauma team leader deems the injuries incompatible with life&#xD;
&#xD;
          -  More than 3 hours have elapsed from the time of injury&#xD;
&#xD;
          -  Prisoner (as defined as someone admitted from a correctional facility)&#xD;
&#xD;
          -  Known &quot;Do Not Resuscitate&quot; orders&#xD;
&#xD;
          -  Enrolled in a concurrent ongoing interventional, randomized clinical trial&#xD;
&#xD;
          -  Patients who wear &quot;opt out&quot; bracelet for study&#xD;
&#xD;
          -  Obvious pregnancy&#xD;
&#xD;
          -  Severely burned&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bryan A Cotton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bryan A Cotton, MD</last_name>
    <phone>713-500-7313</phone>
    <email>Bryan.A.Cotton@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erin E Fox, PhD</last_name>
    <phone>713-500-7965</phone>
    <email>Erin.E.Fox@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erin E Fox, PhD</last_name>
      <phone>713-500-7965</phone>
      <email>Erin.E.Fox@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jeanette Podbielski, RN, BSN</last_name>
      <phone>(713) 500-6407</phone>
      <email>Jeanette.M.Podbielski@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Sussex County Hospital</name>
      <address>
        <city>Brighton</city>
        <zip>BN2N 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Southmead Hospital</name>
      <address>
        <city>Bristol</city>
        <zip>BS10 5NB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Addenbrooke's Hospital</name>
      <address>
        <city>Cambridge</city>
        <zip>CB2 0QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <zip>CF14 4XW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of Coventry and Warwickshire</name>
      <address>
        <city>Coventry</city>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hull Royal Infirmary</name>
      <address>
        <city>Hull</city>
        <zip>HU3 2JZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Aintree</name>
      <address>
        <city>Liverpool</city>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. George's Hospital</name>
      <address>
        <city>London</city>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Salford Royal Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Infirmary</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queens Medical Centre</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9UD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Plymouth</city>
        <zip>PL6 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Preston Hospital</name>
      <address>
        <city>Preston</city>
        <zip>PR2 9HT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital of North Staffordshire</name>
      <address>
        <city>Stoke-on-Trent</city>
        <zip>ST4 6QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Lucas</last_name>
      <phone>+44 1223 588 720</phone>
      <email>cryostat2@nhsbt.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 6, 2021</study_first_submitted>
  <study_first_submitted_qc>January 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>October 9, 2021</last_update_submitted>
  <last_update_submitted_qc>October 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Bryan Cotton</investigator_full_name>
    <investigator_title>Professor of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

